Keith R. Jerome

Source: Wikipedia, the free encyclopedia.
Keith R. Jerome
EducationGeorgetown College
Duke University
Scientific career
FieldsVirology
InstitutionsUniversity of Washington

Keith R. Jerome is an American

Alexander Greninger shared the Washington Innovator of the Year award for developing the laboratory based assay for detecting COVID-19.[5] He was senior author on a research article published in Science describing the cryptic transmission of SARS-CoV-2 alongside Trevor Bedford, Alexander Greninger, Jay Shendure, and Helen Chu.[6] Regarding the origin of SARS-CoV-2 he reported that the live market in Wuhan was more likely than a lab leak of the virus.[7]

Jerome studies the ways in which these viruses evade the immune system and potential therapies for these infections. Jerome and his colleagues study the uses of precision gene-editing tools like

Herpes virus by using the DNA-cutting tools of gene therapy. Initial research showed these techniques could knock out small quantities of latent virus.[8] He and his colleagues are exploring this approach in combination with blood stem cell transplants as a means of curing HIV
.

Academic and medical appointments

  • Professor, Department of Laboratory Medicine and Pathology, University of Washington, 2012–present
  • Head, Virology Division, Laboratory Medicine, University of Washington, 2012–present
  • Full professor, Fred Hutchinson Cancer Research Center, 2015–present

Education and training

  • Georgetown College, B.S., Chemistry, summa cum laude, 1985
  • Duke University, PhD, Microbiology and Immunology, 1992
  • Duke University, MD, May 1993
  • Resident Physician, Department of Pathology, University of Washington, 1993-1995
  • Resident Physician, Department of Laboratory Medicine, University of Washington, 1995-1997
  • Senior Fellow, Virology Division, Department of Laboratory Medicine, University of Washington, 1997-1998

Selected publications

References